Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where
Dr Lal Pathlabs Ltd Q1FY25; 29% rise in Profits
Categories
Diagnostics & Research
Thyrocare Technologies Ltd Q3FY24; 15% rise in Profits
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to
Vijaya Diagnostic Centre Ltd Q3FY24; 62% rise in Profits
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Tarsons Products Ltd Q2FY24; 38% fall in Profits
Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others'
Vijaya Diagnostic Centre Ltd Q2FY24; 48% rise in Profits
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
SastaSundar Ventures – A new player in the e-pharmacy space
“We spent last few years building most efficient Digital Healthcare Platform in terms of Cost, Consumer Experience and Capital. The continued focus
Apollo Hospital: The one stop healthcare service
“At a time when the world is realizing the importance of prevention more than ever before, it is a matter of pride
Vijaya Diagnostic Centre Limited (VIJAYA) Q2 FY23 Earnings Concall Transcript
Vijaya Diagnostic Centre Limited (NSE:VIJAYA) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Suprita Reddy -- Chief Executive Officer Narasimha
Metropolis Healthcare Limited (METROPOLIS) Q2 FY23 Earnings Concall Transcript
Metropolis Healthcare Limited (NSE:METROPOLIS) Q2 FY23 Earnings Concall dated Nov. 08, 2022 Corporate Participants: Ameera Shah -- Managing Director Rakesh Agarwal --
Sun Pharmaceutical Industries Limited Q2 FY23 Earnings Conference Call Insights
Key highlights from Sun Pharmaceutical Industries Limited (SUNPHARMA) Q2 FY23 Earnings Concall Q&A Highlights: [00:16:46] Tushar Manudhane of Motilal Oswal asked about
Dr Lal PathLabs Ltd (LALPATHLAB) Q1 FY23 Earnings Concall Transcript
Dr Lal PathLabs Ltd (NSE:LALPATHLAB) Q1 FY23 Earnings Concall dated Jul. 28, 2022 Corporate Participants: Arvind Lal -- Executive Chairman Om Prakash
Research Summary Dr Lal PathLabs Limited Q4 FY 2022
Overview Dr Lal PathLabs Limited is an Indian diagnostic company. It was incorporated in 1949. The headquarters is situated in Delhi, India. It
Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY22 Earnings Concall Transcript
Dr Lal PathLabs Ltd (NSE: LALPATHLAB) Q4 FY22 Earnings Concall dated May. 17, 2022 Corporate Participants: Nishid Solanki -- Arvind Lal -- Executive Chairman Om
IPO News: Vijaya Diagnostic plans to offer up to 3.57 crore shares for sale
Diagnostic services have become the cornerstone of healthcare, especially for recommending treatments and monitoring post-treatment recovery. The diagnostics industry in India, valued